7+3 (daunorubicin) for AML | ChemoExperts
The “7+3” regimen in acute myeloid leukemia | Haematologica
Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas | Haematologica
Prevention and Treatment of Cytarabine-Induced Keratoconjunctivitis
Chemotherapy dosing schedule. The schedule for ARA-C (200 mg/m 2 /d),... | Download Scientific Diagram
Efficacy and safety of different doses of cytarabine in consolidation therapy for adult acute myeloid leukemia patients: a network meta-analysis | Scientific Reports
Molecules | Free Full-Text | Exploring the Antitumor Mechanism of High-Dose Cytarabine through the Metabolic Perturbations of Ribonucleotide and Deoxyribonucleotide in Human Promyelocytic Leukemia HL-60 Cells
High Risk of Relapse with Intermediate Dose Cytarabine for Consolidation in Young Favorable Risk AML Patients Following Induction with 7+3 - ScienceDirect
Cytarabine Dose for Acute Myeloid Leukemia | NEJM
Cytarabine Dose for Acute Myeloid Leukemia | NEJM
American Journal of Hematology | Blood Research Journal | Wiley Online Library
For relapsed ALL patients under 65 years of age, the salvage... | Download Scientific Diagram
Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients - ScienceDirect
High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement | Semantic Scholar
Chemotherapy regimen. | Download Table
Acute myeloid leukaemia (AML) and cytarabine pharmacogenomics
Flowchart of regimen consisting of cladribine, cytarabine and etoposide... | Download Scientific Diagram
A Randomized Comparison of Modified Intermediate-dose Ara-C versus High-dose Ara-C in Post-remission Therapy for Acute Myeloid Leukemia | Anticancer Research
1930-R-MPV/high dose cytarabine overview | eviQ
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study | Leukemia
FLAG-IDA chemotherapy for leukemia- AML | ChemoExperts
Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death | BMC Cancer | Full Text
